An increasing number of structural abnormalities, metabolic factors, and infective agents have been recognised in association with hepatobiliary disorders in early infancy.' 2 These factors clearly influence the prognosis for affected infants. The incidence of persisting hepatic abnormalities reported in children in whom no associated features were found is controversial ranging from 10 of 70 patients in Odievre's series3 to 21 of 59 in Danks' series.4 Such variation in outcome may be due to case selection, referral patterns, and completeness of follow up.
To assess the relative incidence of the various causes and factors associated with hepatobiliary disease in infancy and their influence on the long term prognosis, a prospective study of all such infants in a defined area of south east England was carried out between January 1971 and December 1973. 5 The cases identified have been regularly reassessed up to the age of 10 years.
Patients and methods
The area studied was a NHS administrative region in south east England approximately 70 miles long and 50 miles wide. It includes a quadrant of inner London, the predominantly industrial southern shore of the Thames estuary, and a largely agricultural area extending down to the south east coast.
The total population is approximately 3½/2 million, with 134 000 births during the three year period of the study. Criteria for inclusion in the study were (1) conjugated hyperbilirubinaemia lasting for more than two weeks in the first four months of life and (2) Previous obstetric difficulties were more common in the mothers of those with idiopathic disease, five having had previous miscarriages or stillbirths and three having had terminations. There was one previous stillbirth in a mother of an infant with biliary atresia. Preterm deliveries (five infants) and infants small for gestational age (11 infants) were common in the idiopathic group. Perinatal problems such as respiratory distress, hypoglycaemia, and convulsions occurred in 10 of the idiopathic group. There were no cases of preterm deliveries or infants light for gestational age in either the biliary atresia or the a1 antitrypsin deficient groups. All the infants with intrauterine infections and chromosomal abnormality were light for gestational age.
Ventricular septal defect occurred in one infant with biliary atresia and one child with idiopathic hepatitis. Dextrocardia and pulmonary stenosis were detected in one other infant with biliary atresia, and congenital heart block in one infant with idiopathic hepatitis.
Bacterial infections occurred in all diagnostic categories. Three infants, including one with cytomegalovirus infection, had septicaemia, nine had a urinary tract infection, and nine had signs suggestive of infection which improved on antibiotic treatment, although bacteriological investigations were negative. In neither of these categories did antibiotic treatment clearly improve liver function. Pathogens were isolated in specimens from 13 other patients but none of these had symptoms or signs of infection. It is not known whether infection was causal or coincidental in any of these.
Outcome (Table 2) . Extrahepatic biliary atresia Nine of the 11 cases died by 2 years of age after surgery had been ineffective. None had undergone portoenterostomy. One survived with partial bile drainage until 5 years of age. The sole survivor is aged 11 years and is leading a normal life, although mildly jaundiced with gross splenomegaly and abnormal liver function tests. He had an oesophageal resection for repeated haematemeses due to varices in 1976, and in 1984 required injection of varices because of recurrent bleeding. affected sibling and the other three children were essentially similar to the above except two showed prominent giant cell transformation of hepatocytes, but the portal tract fibrosis was mild in all. Repeat liver biopsies at 8, 11, 11, and 12 years respectively showed no evidence of cholestasis, hepatocellular necrosis, or cellular infiltrate but all showed persisting mild increase in fibrosis both intralobularly and in the portal tract. The severity of liver disease in infancy in the two patients with persisting hepatic abnormalities when compared with the 25 who recovered completely was similar, as assessed by the duration of jaundice, period of acholic stools, and the degree of abnormality of biochemical tests of liver function. The initial biopsy in one of those with persisting liver disease had, as detailed above, increased fibrosis but in the other findings were similar to those who recovered completely.
Four of the 25 without liver disease, attend schools for the educationally subnormal. Two of these were light for gestational age and one was diagnosed as having congenital hypothyroidism at 6 months of age. One child is below the third centile for both weight and height and one is below the third centile for weight only. Both were light for gestational age. The remaining children are normally grown and leading normal lives.
Discussion
The stimulus to undertake this study was the observation that children referred with chronic liver disease have frequently presented in early infancy with jaundice associated with some form of 'hepatitis syndrome'. The frequency of this liver disease in infancy is clearly dependent on the criteria used in identifying these patients, modes of case ascertainment, and referral patterns as well as the frequency of genetic or environmental causes in the community studied. By including only infants who have had conjugated hyperbilirubinaemia for at least two weeks we hoped to identify infants who should be referred and who might develop chronic liver disease. Infants with transient cholestasis associated with treatable bacterial infections or metabolic disorders such as galactosaemia, which had been effectively treated would not necessarily have been included. The incidence of this disorder, 1 per 2500 live births, must be considered in respect of these criteria.
Incidence figures quoted in other studies1 2 6 have ranged from 1 in 500 in the UK to 1 in 9000 in Norway. In the former study duration of jaundice was not indicated, so possibly included transient mild cases, while the latter was limited to infants with persistent complete cholestasis who were referred for consideration of biliary atresia.
Infective, genetic, and structural factors associated with hepatobiliary disease were identified in 25% of the cases in this series. The cause of liver disease in most is largely unexplained. Impaired blood supply to the biliary system7 may be one factor which initiates the inflammatory destruction of bile ducts in biliary atresia. Reovirus infection8 has been implicated in both intrahepatic and biliary disease. An increasing number of metabolic disorders and infective agents have been associated with liver disease but the mechanism of liver injury is uncertain. This is so even where the association with liver disease is strong as in a, antitrypsin deficiency in which only 50% have abnormal liver function as infants and only 10% have clinically evident liver disease.9 10 The high incidence of obstetric problems, intrauterine growth retardation, and perinatal difficulties in those with idiopathic disease is striking, but whether the liver damage had the same primary cause or was a sequel to these problems could not be determined. Only two sibships with affected infants were identified in contrast to Danks' and Henriksen's series where familial occurrence was much higher. 1 In that study, however, liver biopsy was not used to assess the severity of liver disease and the incidence of cirrhosis may be underestimated. In two large series of cases presenting with jaundice in infancy, 25% had already died from cirrhosis by the age of 17 years, a further 25% had cirrhosis, while approximately 30% had persisting liver disease.13 1 The prognosis of infants with cryptogenic intrahepatic disease has been encouragingly good with only two deaths and two with signs of persisting liver disease. A similarly low incidence of persistent abnormality has been reported in Japan,15 but other groups have reported more severe disease.24 In these series not only did intrahepatic disease carry a worse prognosis but those who also had a family history of the syndrome fared badly. In our series one of two infants from families with a positive history developed cirrhosis. It seems likely that the familial cases may be attributable to some unrecognised genetic or metabolic factor. No infants with intrahepatic bile duct hypoplasia, a cause of chronic liver disease, were identified, although possibly the two infants who died might ultimately have developed features of this disorder.
The prognosis in this series did not seem to be related to the duration or intensity of jaundice or the presence of acholic stools. Nor did it seem related to the nature of the histological change in the early liver biopsy.
The possible deleterious effect of laparotomy on the long term prognosis of cholestatic liver disease in infants remains controversial3 16-18 and whether it contributed to the death of one of the two infants with intrahepatic disease in this series is uncertain. Laporotomy is now rarely required for diagnosis, which is fortunate, as the findings at laporotomy may be difficult to interpret'9 and inappropriate destructive surgery undertaken. 20 None of the survivors in this series has symptomatic liver disease, although one has inactive cirrhosis on liver biopsy. Sixteen per cent have intellectual retardation, possibly related to perinatal problems. Of these, one child had congenital hypothyroidism. At the time of the study the association of hypothyroidism with conjugated hyperbilirubinaemia had not been recognised. The 
